Science, environment & health research | University of Surrey
2019 Science Program by American Academy of Neurology - Issuu
Author Index - 2021 - Hepatology - Wiley Online Library
Combination of the W boson polarization measurements in top quark decays using ATLAS and CMS data at $\sqrt{s} = $ 8 TeV - CERN Document Server
Combination of the W boson polarization measurements in top quark decays using ATLAS and CMS data at $\sqrt{s} = $ 8 TeV - CERN Document Server
Technology in health & wellness research | University of Surrey
2021 Print Program
Digital societies research | University of Surrey
PAA2016 Annual Meeting Final Program
Department of Sociology people | University of Surrey
Rachel Brooks and Rob Meadows lead Sociology Editorial Team - Everyday Society - The British Sociological Association
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Department of Sociology people | University of Surrey
Dialogues: Research events series | University of Surrey
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial - The Lancet
Technology in health & wellness research | University of Surrey
Digital societies research | University of Surrey
Rachel Brooks and Rob Meadows lead Sociology Editorial Team - Everyday Society - The British Sociological Association
Network Spring 2022 v61 with feature_Layout 1
Best Lawyers Fall Business Edition 2019 by Best Lawyers - Issuu
![PDF] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7e47dc56cdbe3e85b1d2ddfc027cb5733d45c10/5-Figure1-1.png "PDF] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | Semantic Scholar")
PDF] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial | Semantic Scholar
